Literature DB >> 28607921

Graft predominance after double umbilical cord blood transplantation: a review.

Jan J Cornelissen1, Burak Kalin1, Cor H J Lamers2.   

Abstract

Several parameters are involved in graft predominance after double umbilical cord blood transplantation (dUCBT), of which T-cell alloreactivity between the grafts is now considered to be the major denominator. We recently showed that alloreactive CD4+ T-cells originating from the predominant CBU recognize HLA-class II allele mismatches and can readily be detected in the majority of patients. In addition, it was shown that HLA-class II allele-specific CD4+ T-cells were able to recognize primary leukemic cells when the mismatched HLA-class II allele was shared between the rejected CBU and the patient. These results further underscored the role of alloreactive T-cells, notably class II specific CD4+ T-cells, in graft-versus-graft reactions and in graft-versus-leukemia after dUCBT.

Entities:  

Keywords:  Double umbilical cord blood transplantation (dUCBT); T-cell alloreactivity; graft predominance; graft-versus-graft reactions; graft-versus-leukemia

Year:  2017        PMID: 28607921      PMCID: PMC5460132          DOI: 10.21037/sci.2017.05.09

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  35 in total

1.  Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice.

Authors:  Takashi Yahata; Kiyoshi Ando; Hiroko Miyatake; Tomoko Uno; Tadayuki Sato; Mamoru Ito; Shunichi Kato; Tomomitsu Hotta
Journal:  Mol Ther       Date:  2004-11       Impact factor: 11.454

2.  Early engraftment kinetics of two units cord blood transplantation.

Authors:  H J Kang; S H Kho; M K Jang; S H Lee; H Y Shin; H S Ahn
Journal:  Bone Marrow Transplant       Date:  2006-06-19       Impact factor: 5.483

3.  Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells.

Authors:  Cor H J Lamers; Ralph Willemsen; Pascal van Elzakker; Sabine van Steenbergen-Langeveld; Marieke Broertjes; Jeannette Oosterwijk-Wakka; Egbert Oosterwijk; Stefan Sleijfer; Reno Debets; Jan W Gratama
Journal:  Blood       Date:  2010-10-01       Impact factor: 22.113

4.  Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.

Authors:  Sharon Avery; Weiji Shi; Marissa Lubin; Anne Marie Gonzales; Glenn Heller; Hugo Castro-Malaspina; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Juliet N Barker
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

5.  In vitro evaluation of graft-versus-graft alloreactivity as a tool to identify the predominant cord blood unit before double cord blood transplantation.

Authors:  Antonia Moretta; Gabriella Andriolo; Daniela Lisini; Miryam Martinetti; Annamaria Pasi; Paolo Rebulla; Davide Soligo; Rosaria Giordano; Lorenza Lazzari; Rita Maccario
Journal:  Biol Blood Marrow Transplant       Date:  2012-01-03       Impact factor: 5.742

6.  Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Authors:  Jon J van Rood; Cladd E Stevens; Jacqueline Smits; Carmelita Carrier; Carol Carpenter; Andromachi Scaradavou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

7.  Cord-Blood Transplantation in Patients with Minimal Residual Disease.

Authors:  Filippo Milano; Ted Gooley; Brent Wood; Ann Woolfrey; Mary E Flowers; Kristine Doney; Robert Witherspoon; Marco Mielcarek; Joachim H Deeg; Mohamed Sorror; Ann Dahlberg; Brenda M Sandmaier; Rachel Salit; Effie Petersdorf; Frederick R Appelbaum; Colleen Delaney
Journal:  N Engl J Med       Date:  2016-09-08       Impact factor: 91.245

8.  Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome.

Authors:  Gérard Michel; Claire Galambrun; Anne Sirvent; Cecile Pochon; Benedicte Bruno; Charlotte Jubert; Anderson Loundou; Ibrahim Yakoub-Agha; Noel Milpied; Patrick Lutz; Aude Marie-Cardine; Virginie Gandemer; Didier Blaise; Mauricette Michallet; Fanny Rialland; Cecile Renard; Claire Oudin; Sophie Esmiol; Mylene Seux; Karine Baumstarck; Mohamad Mohty; Vanderson Rocha; Jean-Hugues Dalle
Journal:  Blood       Date:  2016-04-20       Impact factor: 22.113

9.  Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.

Authors:  Duncan Purtill; Cladd E Stevens; Marissa Lubin; Doris Ponce; Alan Hanash; Sergio Giralt; Andromachi Scaradavou; James W Young; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-23       Impact factor: 5.742

Review 10.  Cord blood versus haploidentical stem cell transplantation for hematological malignancies.

Authors:  Natasha Kekre; Joseph H Antin
Journal:  Semin Hematol       Date:  2016-01-15       Impact factor: 3.851

View more
  1 in total

1.  Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation.

Authors:  Rachael Hough; Andre Lopes; Pip Patrick; Nigel Russell; Kavita Raj; Eleni Tholouli; John A Snowden; Matthew Collin; Nadjet El-Mehidi; Anthony Lawrie; Laura Clifton-Hadley; Paul Veys; Charles Craddock; Stephen Mackinnon; Gordon Cook; Bronwen Shaw; David Marks
Journal:  Blood Adv       Date:  2022-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.